Your session is about to expire
← Back to Search
Enhanced Prehabilitation for Surgery
N/A
Recruiting
Led By Cindy Kin, MD, MS
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Competent to provide informed consent
Adult patients (≥ 18 years)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days after surgery
Awards & highlights
Study Summary
This trial will test whether a personalized prehabilitation program can improve outcomes after surgery by reducing post-surgical pain, minimizing opioid consumption, and accelerating functional recovery.
Who is the study for?
This trial is for English-speaking adults who are about to have major elective surgery under general anesthesia in at least two weeks. It's not for those with a high surgical risk (ASA score 4+), cognitive disabilities, or physical conditions that prevent exercise, nor pregnant or breastfeeding women.Check my eligibility
What is being tested?
The study tests a personalized 'prehab' program designed to boost patients' immune systems before surgery. This includes exercise, nutrition, stress reduction, and mental training tailored to individual needs based on biological markers.See study design
What are the potential side effects?
Since the interventions involve non-invasive prehabilitation methods like stress management and physical exercises rather than medications, side effects may include typical exercise-related issues such as muscle soreness or fatigue.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I understand and can agree to the study's procedures and risks.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately preoperatively
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately preoperatively
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Composite immunological score
Secondary outcome measures
6 Min Walk Test
Amsterdam Preoperative Anxiety and Information Scale
Body Mass Index
+13 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Personalized prehabilitationExperimental Treatment4 Interventions
Patients will participate in a personalized health optimization program combining one-on-one coaching, tailored to each patient's physical, nutritional, well-being and cognitive status baseline. Prehabilitation will last from a minimum of 14 days to a maximum of 42 days before surgery
Group II: Standard prehabilitationActive Control1 Intervention
Patients in the control group will be provided with standard instructions in a hard-copy form specific to prehabilitation before surgery associating physical, nutritional, stress-reduction and cognitive recommendations without any personalized coaching for at least 14 days prior to surgery.
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,341,540 Total Patients Enrolled
Cindy Kin, MD, MSPrincipal InvestigatorStanford University
Brice Gaudilliere, MD, PhDPrincipal Investigator - Stanford University
Stanford University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am receiving palliative care or have a high surgery risk.I have given my consent to participate in the study.You have existing medical conditions or physical limitations that make it unsafe for you to exercise.I expect to stay in the hospital for less than 48 hours.I understand and can agree to the study's procedures and risks.I am under legal guardianship.I am 18 years old or older.You have a condition that affects your thinking and understanding, such as a progressive neurological or brain disease.I will have a major surgery under general anesthesia in more than 14 days.
Research Study Groups:
This trial has the following groups:- Group 1: Personalized prehabilitation
- Group 2: Standard prehabilitation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger